Rapid photolytic release of cytidine 5′-diphosphate from a coumarin derivative: a new tool for the investigation of ribonucleotide reductases
摘要:
In order to study the range-range radical transfer in the Escherichia coli ribonucleotide reductase (RNR), caged cytidine 5'-diphospliate (CDP) 1 was synthesized, which contains the photolabile (7-diethylaminocoumarin-4-yl)methyl moiety. The caged CDP 1 triggers the release of CDP when irradiated at wavelengths between 365 and 436 nm. The rate constant of the formation of alcohol 2 and cytidine 5'-diphosphate 3 is 2 x 10(8) s(-1) and the quantum efficiency for the disappearance of caged CDP 1 is 2.9%. (C) 2001 Elsevier Science Ltd. All rights reserved.
Rapid photolytic release of cytidine 5′-diphosphate from a coumarin derivative: a new tool for the investigation of ribonucleotide reductases
摘要:
In order to study the range-range radical transfer in the Escherichia coli ribonucleotide reductase (RNR), caged cytidine 5'-diphospliate (CDP) 1 was synthesized, which contains the photolabile (7-diethylaminocoumarin-4-yl)methyl moiety. The caged CDP 1 triggers the release of CDP when irradiated at wavelengths between 365 and 436 nm. The rate constant of the formation of alcohol 2 and cytidine 5'-diphosphate 3 is 2 x 10(8) s(-1) and the quantum efficiency for the disappearance of caged CDP 1 is 2.9%. (C) 2001 Elsevier Science Ltd. All rights reserved.
The invention relates to novel caged ceramide 1-phosphate (C1P) and the method of using them for delivering C
1
P intracellularly in vitro and in vivo, for research and therapeutic purposes.
Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors
作者:Gloria Somalo-Barranco、Carme Serra、David Lyons、Hugh D. Piggins、Ralf Jockers、Amadeu Llebaria
DOI:10.1021/acs.jmedchem.2c00717
日期:2022.8.25
US9359389B2
申请人:——
公开号:US9359389B2
公开(公告)日:2016-06-07
[EN] CAGED CERAMIDE-1-PHOSPHATE DERIVATIVES<br/>[FR] DÉRIVÉS DE CÉRAMIDE-1-PHOSPHATE BLOQUÉ
申请人:UNIV CITY NEW YORK RES FOUND
公开号:WO2011056599A2
公开(公告)日:2011-05-12
The invention relates to novel caged ceramide 1-phosphate (C1P) and the method of using them for delivering C1P intracellularly in vitro and in vivo, for research and therapeutic purposes.